BeOne Medicines
ONC
#732
Rank
NZ$56.45 B
Marketcap
NZ$510.19
Share price
2.79%
Change (1 day)
13.89%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): NZ$0.30 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are NZ$4.97 Billion. In 2024 the company made an earning of -NZ$0.97 Billion, an increase over its 2023 earnings that were of -NZ$2.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.30 B-131.62%
2024 -NZ$0.97 Billion-52.95%
2023 -NZ$2.05 Billion-32.52%
2022 -NZ$3.04 Billion24.39%
2021 -NZ$2.44 Billion-13.21%
2020 -NZ$2.81 Billion72.69%
2019 -NZ$1.63 Billion36.01%
2018 -NZ$1.2 Billion616.83%
2017 -NZ$0.17 Billion-15.24%
2016 -NZ$0.2 Billion107.91%
2015 -NZ$94.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion-187.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.77 Million-109.94%๐Ÿ‡บ๐Ÿ‡ธ USA